-

SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Class Action Against DocuSign, Inc. (DOCU)

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased DocuSign, Inc. (NASDAQ: DOCU) securities between March 27, 2020 and December 2, 2021. The complaint alleges violations of the Securities Exchange Act of 1934. DocuSign offers the Agreement Cloud, a cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device.

If you suffered a loss due to DocuSign Inc.'s misconduct, click here.

DocuSign, Inc. (DOCU) Made Material Misstatements Regarding its Business Prospects

According to the complaint, during the class period, defendants failed to disclose the role the COVID-19 pandemic had on its growth, including the positive impact on DocuSign's business. Defendants also downplayed the impact that a 'return to normal' would have on the Company's growth and business.

On December 2, 2021, DocuSign held an earnings conference call for its third quarter fiscal year 2022, revealing that its anticipated growth for the fourth quarter 2022 would be lower than expected. The Company explained that the growth boost from the COVID-19 pandemic had deteriorated earlier than expected. In a press release issued the same day, DocuSign provided guidance for the fourth quarter fiscal year 2022. The guidance provided midpoint revenue guidance of $560 million, missing analysts' consensus estimates of $573.8 million and a billing guidance of $653 million, missing consensus estimates of $704.5 million. On this news, DocuSign's stock price plummeted $98.73 per share, or over 42%, to close at $135.09 per share on December 3, 2021.

If you purchased shares of DocuSign, Inc. (DOCU) between March 27, 2020 and December 2, 2021, you have until February 22, 2022, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against DocuSign, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Notice: Robbins LLP Informs Investors of the Super Micro Computer, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Super Micro Computer, Inc. (NASDAQ: SMCI) securities between April 30, 2024 and March 19, 2026. Super Micro is a technology company that designs, develops, and manufactures high-performance server and storage systems, primarily for artificial intelligence (“AI”), data center, and cloud solutions customers. For more information, submit a form,...

BlackRock TCP Capital Corp. Investor Alert - TCPC Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired BlackRock TCP Capital Corp. (NASDAQ: TCPC) securities between November 6, 2024 and January 23, 2026. BlackRock TCP is a business development company that raises funds from investors and then uses those funds to make loans to small and midsize businesses as an alternative to bank financing. For more information, submit a form, email attorney Aa...

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASDAQ: MREO) American Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on the development of therapeutics for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the alleg...
Back to Newsroom